September 6th, 2010
Our main aim is to supply research teams with chemotherapy drugs to aid in the fight to cure cancer.
The most commonly used combination of chemotherapy drugs for pleural mesothelioma is pemetrexed and cisplatin. Sometimes pemetrexed is combined with carboplatin. Other combinations or individual drugs may be used, including
For peritoneal chemotherapy into a vein, cisplatin and pemetrexed is the most common combination but one or more of the following drugs may be used
Tags: carboplatin, cisplatin, Cyclophosphamide, Dacarbazine, Doxorubicin, Gemcitabine, Gemcitabine Base, Gemcitabine Hydrochloride, Irinotecan, Mitomycin, pemetrexed, peritoneal chemotherapy, pleural mesothelioma, Raltitrexed, Tomudex, Vinorelbine
Posted in Chemotherapy, Mesothelioma, Popular Research Chemical | No Comments »
August 31st, 2010
Two-thirds of Americans are obese or overweight, according to the Centers for Disease Control and Prevention.
The US Food and Drug Administration plans on reviewing three new anti-obesity drugs by the end of 2010. The FDA will announce its decision on two of these drugs within the next few months.
LGM Pharma supplies the following Active Pharmaceutical Ingredients (APIs) used to treat obesity:
The combination of the drugs Phentermine and Topiramate (trade name Qnexa). It is an investigational medication for the treatment of obesity and related conditions such as type 2 diabetes. It has been found to lower blood pressure and cholesterol. FDA’s advisory committee voted not to approve Qnexa due to the potential side effects of the drug.
Another obesity drug is a combination of the two approved drugs Bupropion and Naltrexone. In clinical trials, patients taking the sustained-release formulation (trade name Contrave) combined with diet and exercise, lost more weight than patients taking a placebo following the same diet and exercise program.
Lorcaserin is different from the previous two anti-obesity drugs under review in that it is a new molecule, not a combination of existing, approved medications. FDA’s advisory panel will meet on Sept. 16, 2010, to discuss Lorcaserin, and Oct. 22, 2010, is the PDUFA date (one week before Qnexa).
Tags: Active Pharmaceutical Ingredients, Anti Obesity, api, Obesity, Popular Products
Posted in Anti-Migraine, Compounding API, General API, New Molecule, Popular Research Chemical | No Comments »
August 12th, 2010
Nalbuphine HCL (Nalbuphine Hydrochloride) is a synthetic opioid used commercially as an analgesic under a variety of trade names, including Nubain. It is noteworthy in part for the fact that at low dosages, it is found much more effective by women than by men, and may even increase pain in men, leading to its discontinuation in the UK in 2003.
Inquire about Nalbuphine HCL price and availability >
LGM Pharma’s team of Compounding API’s task managers have extensive knowledge of Nalbuphine. Our expert knowledge of products allows us to keep a close eye on our competitors. We also adhere to the latest FDA/CVM rulings and regulations such as being CGMP Certified, and by using FDA approved supply sources with registered NDC#’s.
Our Compounding APIs are geared specifically for the Compounding Industry. All of our superior quality API’s are from GMP certified and US-FDA registered manufacturers with NDC listings. All products are supplied in original manufacturers packing, with the manufacturer’s labels and NDC details.
if you would like to compound a product that is not on LGM Pharma’s Compounding APIs list, contact us, and our excellent customer support will assist you with your requirements.
Tags: Active Pharmaceutical Ingredients, api, Compounding API's, Nalbuphine HCL, pharmaceutical ingredient, Products
Posted in Compounding API | No Comments »
August 12th, 2010
TAPI (Teva Active Pharmaceutical Ingredients): TAPI is an international supplier of active pharmaceutical ingredients, with more than $1.9 Billion in annual sales. TAPI employs over 4,600 professionals worldwide and boasts a portfolio of over 290 active pharmaceutical ingredients. TAPI is a stand alone business unit within Teva Pharmaceutical Industries Limited and as its mother company is headquartered in Israel. TAPI’s customers are leading generic & innovative pharmaceutical manufacturers.
Teva API division (TAPI) manufactures over 315 different API’s covering various theraputic categories, and have registered 226 US-DMF’s as well as 83 EDQM COS’s up till date. TAPI group factories include well known names in the global pharmaceutical landscape, such as IVAX (Czech Republic), Sicor (Italy, Mexico), Pliva (Croatia), TPW Biogal (Hungary), PFC (Italy). All the TAPI group factories are fully regulated and approved by global regulatory authorizations such as the US-FDA, MHRA and others.
LGM and TAPI
In continuation with our efforts to bring only the finest quality API’s to our clients while minimizing any regulatory problems and quality issues, we are delighted to inform you that our company LGM Pharma has now been selected as the Sole Distributor of Teva for their extensive API portfolio, for the US pharmacy compounding market.
TAPI are widely recognized as the world-leader in terms of their API production, excellent GMP quality assurance and extensive regulatory position. We at LGM Pharma are proud to be able to bring to you all of these advantages!
Please do not hesitate to contact us for any API’s that are produced by any of the TAPI group factories – Teva, IVAX, Sicor, Pliva and others, and we will be glad to be in touch for any price quotations that may be required.
Please see our agency appointment letter, TAPI Products PDF, TAPI Specialty Portfolio PDF, and our TAPI Portfolio for Injectables PDF.
Tags: Active Pharmaceutical Ingredients, pharmaceutical ingredient, TAPI, TAPI Products, TEVA, TEVA API Products
Posted in Glossary | No Comments »
August 12th, 2010
Active Pharmaceutical Ingredient (API): Any substance or mixture of substances, intended to be used in the manufacture of a drug product and that, when used in the production of a drug, becomes an active ingredient of the drug product. Such substances are intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure or any function of the body of man or animals.
Tags: api, BPC, bulk pharmaceutical chemical, Drug substance, pharmaceutical ingredient
Posted in Glossary | No Comments »
July 21st, 2010
Darunavir Ethanolate is a second-generation protease inhibitor (PIs), designed specifically to overcome problems with the older agents in this class, such as indinavir. Darunavir was designed to form robust interactions with the protease enzyme from many strains of HIV, including strains from treatment-experienced patients with multiple resistance mutations to PIs.
We are proud to present to you this Popular Research Chemical for the research and development of new formulations in the Anti-Retroviral / Anti-HIV chemical category.
It is in our best interest to promote and to further your ongoing research and/or product development efforts. All the enumerated API’s are produced strictly following cGMP guidelines and regulations. It would be our pleasure to supply you with Darunavir Ethanolate, as well as any other new molecules that may be required.
Click here to inquire about price and availability >
Tags: Anti-HIV, Anti-Retroviral, Darunavir, Darunavir Ethanolate, Prezista
Posted in Popular Research Chemical | No Comments »
July 16th, 2010
Educational Facilities, Universities, Research Labs, etc., inquire about any of our Popular Research Chemicals, New Molecules, R&D chemicals and receive a 5% discount on any order. Click here to contact us now.
Tags: Discounts, Educational Discount, Educational Facilities, Research Labs, Universities
Posted in Promotions | No Comments »
May 24th, 2010
Over 15 Years of Experience Supplying the Pharmacy Compounding Industry
LGM Pharma has extensive knowledge and expertise in supplying suitable products to the pharmacy compounding market.
Our expert knowledge of products allows us to keep a close eye on our competitors. We also adhere to the latest FDA/CVM rulings and regulations that are set for the pharmacy compounding industry, and supply API’s only from cGMP certified and FDA approved supply sources.
Technical Capability:
- Accurate shipment paperwork, including all necessary details
- Accurate product labeling as per latest GMP & FDA stipulations
Extensive Global Logistic Coverage:
- Global logistic centers
- Unique forwarding networks throughout all major cities
Tags: product
Posted in Compounding API | No Comments »
May 14th, 2010
Conducting research? Determining whether a product is right for your project? Submit your comments, questions or give your feedback on our LGM Pharma Blog.
We Want to Hear From You!
Whether you are a lab tech, purchasing agent, pharmacist or a happy customer of ours… we want to hear your suggestions!
Tags: customer, feedback, lab, product, purchasing agent, research, suggestions, tech
Posted in Blog About a Topic | No Comments »
May 14th, 2010
LGM Pharma supplies the newest molecules for your R&D needs.
In today’s competitive research & development market, speed and competitiveness can make the difference to project success and increasing your project efficiency. LGM Pharma can help you make that difference. Our goal is to provide fast service and customer feedback.
We also specialize in providing full sourcing options and support for the widest range of the rarest and newest molecules.
New Molecules Directory | New Molecules PDF List
Tags: Etanercept, molecules, rare, sourcing, support
Posted in General API, New Molecule | 2 Comments »
